Table 1.
Clinical, demographic and laboratory characteristics
| Variable | Children n = 298 | Adult n = 1137 |
|---|---|---|
| Age (years) – median (IQR) |
4.92 (1.97-9.51) |
37.79 (29.61-47.77) |
| Female – n (n%) |
157 (52.7) |
688 (60.5) |
| OSS to inclusion (days) – median (IQR) |
3.00 (2.00-4.00) |
3.00 (2.00-5.00) |
| Symptoms – n (n%): | ||
| Fever |
216 (72.5) |
608 (53.5) |
| Cough |
221 (74.2) |
891 (78.4) |
| Loss of smell/taste sensation |
157 (52.7) |
649 (57.1) |
| Shortness of breath |
118 (39.6) |
479 (42.1) |
| Sore throat |
113 (37.9) |
738 (64.9) |
| Headache |
131 (44.0) |
957 (84.2) |
| Nausea/vomiting |
97 (32.6) |
434 (38.2) |
| Diarrhea |
73 (24.5) |
376 (33.1) |
| Conjunctivitis |
49 (16.4) |
385 (33.9) |
| Fatigue |
123 (41.3) |
853 (75.0) |
| Muscle/joint pain |
68 (22.8) |
789 (69.4) |
| Chills |
74 (24.8) |
648 (57.0) |
| Comorbidities – n (n%): | ||
| Systemic arterial hypertension |
1 (0.3) |
190 (16.7) |
| Diabetes mellitus |
1 (0.3) |
59 (5.2) |
| Ischemic heart disease |
0 (0.0) |
17 (1.5) |
| Cardiac insufficiency |
0 (0.0) |
18 (1.6) |
| Chronic obstructive pulmonary disease |
3 (1.0) |
26 (2.3) |
| Asthma |
52 (17.4) |
87 (7.7) |
| Others |
7 (2.3) |
21 (1.8) |
| Laboratory diagnosis: | ||
| SARS-CoV-2 |
49 (16.4) |
420 (36.9) |
| influenza A |
0 (0.0) |
0 (0.0) |
| influenza B |
0 (0.0) |
0 (0.0) |
| Respiratory syncytial virus | 0 (0.0) | 0 (0.0) |
n – absolute frequency, % – relative frequency, md – median, IQR – interquartile range (25th and 75th percentiles), OSS – onset signs and symptoms